These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 36422763)
1. Adjuvant chemotherapy versus adjuvant concurrent chemoradiotherapy after radical surgery for early-stage cervical cancer: a randomized, non-inferiority, multicenter trial. Weng D; Xiong H; Zhu C; Wan X; Chen Y; Wang X; Zhang Y; Jiang J; Zhang X; Gao Q; Chen G; Xing H; Wang C; Li K; Chen Y; Mao Y; Hu D; Pan Z; Chen Q; Cui B; Song K; Yi C; Peng G; Han X; An R; Fan L; Wang W; Xiong T; Chen Y; Tang Z; Li L; Yang X; Cheng X; Lu W; Wang H; Kong B; Xie X; Ma D Front Med; 2023 Feb; 17(1):93-104. PubMed ID: 36422763 [TBL] [Abstract][Full Text] [Related]
2. A Multi-Institutional Retrospective Analysis of Oncologic Outcomes for Patients With Locally Advanced Cervical Cancer Undergoing Platinum-Based Adjuvant Chemotherapy After Concurrent Chemoradiotherapy. Wu N; Su X; Song H; Li Y; Gu F; Sun X; Li X; Cheng G Cancer Control; 2021; 28():1073274821989307. PubMed ID: 33593091 [TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy versus concurrent chemoradiotherapy for high-risk cervical cancer after radical hysterectomy and systematic lymphadenectomy. Takekuma M; Kasamatsu Y; Kado N; Kuji S; Tanaka A; Takahashi N; Abe M; Hirashima Y Int J Clin Oncol; 2016 Aug; 21(4):741-747. PubMed ID: 26857458 [TBL] [Abstract][Full Text] [Related]
4. Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients. Ryu HS; Chun M; Chang KH; Chang HJ; Lee JP Gynecol Oncol; 2005 Feb; 96(2):490-5. PubMed ID: 15661240 [TBL] [Abstract][Full Text] [Related]
5. Role of adjuvant chemotherapy after concurrent chemoradiotherapy in patients with locally advanced cervical cancer. Kou L; Zhang T; Yang X; Peng S; Wang Y; Yuan M; Li M Future Oncol; 2022 May; 18(16):1917-1915. PubMed ID: 35193379 [No Abstract] [Full Text] [Related]
6. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in uterine cervical cancer patients with high-risk factors. Kim YB; Cho JH; Keum KC; Lee CG; Seong J; Suh CO; Kim GE Gynecol Oncol; 2007 Jan; 104(1):58-63. PubMed ID: 16919718 [TBL] [Abstract][Full Text] [Related]
7. Consolidation chemotherapy in early-stage cervical cancer patients with lymph node metastasis after radical hysterectomy. Zhong ML; Wang YN; Liang MR; Liu H; Zeng SY Int J Gynecol Cancer; 2020 May; 30(5):602-606. PubMed ID: 32156715 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Sequential Chemoradiation vs Concurrent Chemoradiation or Radiation Alone in Adjuvant Treatment After Hysterectomy for Cervical Cancer: The STARS Phase 3 Randomized Clinical Trial. Huang H; Feng YL; Wan T; Zhang YN; Cao XP; Huang YW; Xiong Y; Huang X; Zheng M; Li YF; Li JD; Chen GD; Li H; Chen YL; Ma LG; Yang HY; Li L; Yao SZ; Ye WJ; Tu H; Huang QD; Liang LZ; Liu FY; Liu Q; Liu JH JAMA Oncol; 2021 Mar; 7(3):361-369. PubMed ID: 33443541 [TBL] [Abstract][Full Text] [Related]
9. Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors. Seki T; Tanabe H; Nagata C; Suzuki J; Suzuki K; Takano H; Isonishi S; Ochiai K; Takakura S; Okamoto A Jpn J Clin Oncol; 2017 Jan; 47(1):32-38. PubMed ID: 27677664 [TBL] [Abstract][Full Text] [Related]
10. Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients. Mabuchi S; Isohashi F; Okazawa M; Kitada F; Maruoka S; Ogawa K; Kimura T J Gynecol Oncol; 2017 Jan; 28(1):e15. PubMed ID: 27958682 [TBL] [Abstract][Full Text] [Related]
11. The effectiveness of consolidation chemotherapy in high-risk early-stage cervical cancer patients following concurrent chemoradiation after radical surgery. Wang C; Fu C; Ma C; Qian Q; He F; Zhang G Jpn J Clin Oncol; 2023 Jan; 53(2):122-129. PubMed ID: 36408720 [TBL] [Abstract][Full Text] [Related]
12. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience. Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the efficacy between concurrent chemoradiotherapy with or without adjuvant chemotherapy for stage II nasopharyngeal carcinoma. Chen J; Liu T; Sun Q; Jin T Medicine (Baltimore); 2020 Jul; 99(29):e20443. PubMed ID: 32702809 [TBL] [Abstract][Full Text] [Related]
14. Effect of Adjuvant Chemotherapy in Stage III Cervical Cancer Patients Treated with Concurrent Chemoradiation: A Multicenter Study. Atci MM; Akagunduz B; Demir M; Dönmez Yilmaz B; Akin Telli T; Can O; Cil I; Goktas Aydın S; Ozyurt N; Onder AH; Selvi O; Sakin A Oncol Res Treat; 2022; 45(5):254-261. PubMed ID: 35034017 [TBL] [Abstract][Full Text] [Related]
16. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer. Kokka F; Bryant A; Brockbank E; Powell M; Oram D Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525 [TBL] [Abstract][Full Text] [Related]
17. Clinical Role of Adjuvant Chemotherapy after Radical Hysterectomy for FIGO Stage IB-IIA Cervical Cancer: Comparison with Adjuvant RT/CCRT Using Inverse-Probability-of-Treatment Weighting. Jung PS; Kim DY; Lee SW; Park JY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH PLoS One; 2015; 10(7):e0132298. PubMed ID: 26176626 [TBL] [Abstract][Full Text] [Related]
18. Comparison of Postoperative Adjuvant Chemotherapy and Concurrent Chemoradiotherapy for FIGO2018 Stage IIIC1 Cervical Cancer: A Retrospective Study. Kagabu M; Nagasawa T; Tatsuki S; Fukagawa Y; Tomabechi H; Takatori E; Kaido Y; Shoji T; Baba T Medicina (Kaunas); 2021 May; 57(6):. PubMed ID: 34072478 [No Abstract] [Full Text] [Related]
19. Comparison of the survival outcome of neoadjuvant therapy followed by radical surgery with that of concomitant chemoradiotherapy in patients with stage IB2-IIIB cervical adenocarcinoma. Tian T; Gao X; Ju Y; Ding X; Ai Y Arch Gynecol Obstet; 2021 Mar; 303(3):793-801. PubMed ID: 33009996 [TBL] [Abstract][Full Text] [Related]
20. A phase II study of postoperative concurrent carboplatin and paclitaxel combined with intensity-modulated pelvic radiotherapy followed by consolidation chemotherapy in surgically treated cervical cancer patients with positive pelvic lymph nodes. Mabuchi S; Isohashi F; Yokoi T; Takemura M; Yoshino K; Shiki Y; Ito K; Enomoto T; Ogawa K; Kimura T Gynecol Oncol; 2016 May; 141(2):240-246. PubMed ID: 26883141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]